PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
07-Apr-2023 CD Bioparticles Launches mRNA Transfection Reagents for Research Applications CD Bioparticles
05-Apr-2023 Endogena Therapeutics Completes Dose Escalation in the Phase 1/2a Clinical Trial of EA-2353 for the Treatment of Retinitis Pigmentosa Endogena Therapeutics
05-Apr-2023 CluePoints Announces Amit Patel as New CFO CluePoints
05-Apr-2023 Greenphire Appoints Steve Geffon as Chief Commercial Officer Greenphire
30-Mar-2023 Clinical Study of TISSIUM’s COAPTIUM Connect Atraumatic Sutureless Nerve Coaptation System Is Underway in Australia TISSIUM
30-Mar-2023 Modus Therapeutics secures access to bridge financing from longstanding investor Karolinska Development Modus Therapeutics
30-Mar-2023 AlzeCure presents new data at Alzheimer’s conference AD/PD on the potential disease-modifying effect of NeuroRestore ACD856 AlzeCure
30-Mar-2023 Immutep announces expansion of triple combination therapy in first-line non-small cell lung cancer Immutep
30-Mar-2023 AskBio to Present Phase 1b Results Investigating AB-1005 (formerly AAV2-GDNF) as Treatment for Parkinson’s Disease at AD/PDTM 2023 International Conference on Alzheimer's and Parkinson's Diseases Asklepios BioPharmaceutical, Inc
30-Mar-2023 Théa Open Innovation and Galimedix announce strategic partnership to develop and commercialize GAL-101, a Phase 2/3-ready small molecule, to treat ophthalmic indications with high unmet medical need Galimedix Therapeutics
30-Mar-2023 NRG Therapeutics Announces International Scientific Advisory Board NRG Therapeutics
30-Mar-2023 Molecure Announces Full Year Financial 2022 Results – A Year of Significant Progress Molecure S.A.
29-Mar-2023 NETRIS Pharma Doses First Patient in Pancreatic Cancer Clinical Study with NP137 NETRIS Pharma
28-Mar-2023 Evaxion Announces Increased Focus and Fast-Tracking of its New AI Discovery to Patients Evaxion
28-Mar-2023 HMNC Brain Health and Develco Pharma Announce Last Patient Being Randomized in Oral Prolonged-Release Ketamine (KET01) Trial for Treatment-Resistant Depression HMNC Brain Health
28-Mar-2023 Novartis Kisqali® Phase III NATALEE trial meets primary endpoint at interim analysis demonstrating clinically meaningful benefit in broad population of patients with early breast cancer Novartis
28-Mar-2023 Tiziana Life Sciences to Proceed with Phase 2 Clinical Trial in Patients with Non-Active Secondary Progressive Multiple Sclerosis (SPMS) Tiziana Life Sciences
28-Mar-2023 Thermosome Receives Regulatory Approval for First-In-Human Trial with its Lead Program THE001 Thermosome
23-Mar-2023 Citeline Finalist CluePoints Show Advanced AI Capabilities CluePoints
23-Mar-2023 Vaccitech’s VTP-200 Ph 1b/2 Study Demonstrates Favorable Tolerability and Immunogenicity Profile at Interim Analysis in Women with Low-Grade Human Papillomavirus (HPV)-related Cervical Lesions Vaccitech